Physician profile
Rene Williams
NPI 1265556583
$2,671.96
in general payments reported to CMS, 2019-2025
20 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2020: $401 · 2021: $361 · 2022: $583 · 2023: $279 · 2024: $297 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $743 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $743.46 |
| Education | $109.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $645.87 | 2019-2025 | Orilissa, Lo Loestrin Fe |
| Pfizer INC. | $326.91 | 2019-2025 | |
| Amag Pharmaceuticals, INC. | $245.86 | 2019-2020 | |
| Myovant Sciences INC. | $240.55 | 2021-2022 | |
| Daiichi Sankyo INC. | $200.92 | 2020-2025 | Injectafer |
| Astellas Pharma US INC | $195.82 | 2024-2025 | Veozah |
| Sumitomo Pharma America, INC. | $176.23 | 2023-2025 | Myfembree |
| Therapeuticsmd, INC. | $164.28 | 2019-2022 | |
| Minerva Surgical, INC | $102.15 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $65.93 | 2025 | |
| Merck Sharp & Dohme LLC | $64.94 | 2020-2022 | |
| Roche Diagnostics Corporation | $59.89 | 2019-2021 | |
| Avanos Medical | $52.71 | 2019-2022 | |
| Revance Therapeutics, INC. | $24.95 | 2024 | Daxxify |
| Alydia Health | $24.50 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $21.64 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $18.77 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.51 | 2019 | |
| Zyla Life Sciences, INC. | $12.91 | 2020 | |
| Allergan, INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rene Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.